摘要
背景:在医学图像处理中的特征提取仍然是一个挑战,特别是在高维数据集中,其中可用样本的预期数量远远低于特征空间的维数。这在现实世界的数据中是一个常见的问题,特别是在医学图像处理中,尽管图像由数十万个体素组成,但只有少数患者可用。 目的:提取描述性和判别性特征,用维数较少的特征来表示每个样本(图像),这在维度问题的诅咒中尤为重要。 方法:本文通过数据的稀疏表示来解决这个识别问题,并通过结合专门的分类器为多模态图像(PET和MRI)数据分类提供了一个舞台。因此,这里提出了一种有效组合SVC分类器的新方法,该方法使用与每个分类器中的每个类计算的超平面的距离,从而允许在每种情况下选择最有区别的图像模态。每种方式的区别能力也提供有关疾病发展的信息。而与对照受试者(CN)相比,阿尔茨海默病患者(AD)的功能改变明显,结构改变在疾病早期似乎更为相关,影响了轻度认知功能障碍(MCI)患者。 结果:使用来自阿尔茨海默病神经影像学数据库的68 CN,70 AD和111 MCI图像进行分类实验,并通过交叉验证进行评估,以显示所提出的方法的有效性。 CN / AD和CN / MCI分类的准确度高达92%和84%。 结论:本文提出的方法表明,大脑图像的稀疏表示对于编码和传输相关图像特征具有重要意义,因为它们可以在保持轻量级数据交易的同时捕获显着特征。实际上,本文提出的方法优于使用投影方法如主成分分析提取图像代表性特征的分类结果。
关键词: 稀疏特征,多模型数据,轻度认知障碍,支持向量分类器,计算机辅助诊断,ADNI。
Current Alzheimer Research
Title:Discriminative Sparse Features for Alzheimer's Disease Diagnosis Using Multimodal Image Data
Volume: 15 Issue: 1
关键词: 稀疏特征,多模型数据,轻度认知障碍,支持向量分类器,计算机辅助诊断,ADNI。
摘要: Background: Feature extraction in medical image processing still remains a challenge, especially in high-dimensionality datasets, where the expected number of available samples is considerably lower than the dimension of the feature space. This is a common problem in real-world data, and, specifically, in medical image pro- cessing as, while images are composed of hundreds of thousands voxels, only a reduced number of patients are available.
Objective: Extracting descriptive and discriminative features to represent each sample (image) by a small number of features, which is particularly important in classification task, due to the curse of dimensionality problem.
Methods: In this paper we solve this recognition problem by means of sparse representations of the data, which also provides an arena to multimodal image (PET and MRI) data classification by combining specialized classifiers. Thus, a novel method to effectively combine SVC classifiers is presented here, which uses the distance to the hyperplane computed for each class in each classifier allowing to select the most discriminative image modality in each case. The discriminative power of each modality also provides information about the illness evolution; while functional changes are clearly found in Alzheimer’s diagnosed patients (AD) when compared to control subjects (CN), structural changes seem to be more relevant at the early stages of the illness, affecting Mild Cognitive Impairment (MCI) patients.
Results: Classification experiments using 68 CN, 70 AD and 111 MCI images from the Alzheimer's Disease Neuroimaging Initiative database have been performed and assessed by cross-validation to show the effectiveness of the proposed method. Accuracy values of up to 92% and 84% for CN/AD and CN/MCI classification are achieved.
Conclusions: The method presented in this work shows that sparse representations of brain images are of importance for codifying and transferring relevant image features, as they may capture the salient features while maintaining lightweight data transactions. In fact, the method proposed in this work outperforms the classification results obtained using projection methods such as Principal Component Analysis for extracting representative features of the images.
Export Options
About this article
Cite this article as:
Discriminative Sparse Features for Alzheimer's Disease Diagnosis Using Multimodal Image Data, Current Alzheimer Research 2018; 15 (1) . https://dx.doi.org/10.2174/1567205014666170922101135
DOI https://dx.doi.org/10.2174/1567205014666170922101135 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Thrombomodulin Links Coagulation to Inflammation and Immunity
Current Drug Targets The Emerging Role of the Double-Edged Impact of Arachidonic Acid- Derived Eicosanoids in the Neuroinflammatory Background of Depression.
Current Neuropharmacology N-3 (Omega-3) Polyunsaturated Fatty Acids in the Pathophysiology and Treatment of Depression: Pre-Clinical Evidence
CNS & Neurological Disorders - Drug Targets Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers
Anti-Cancer Agents in Medicinal Chemistry The Putative Use of Lithium in Alzheimer’s Disease
Current Alzheimer Research Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review
Current Diabetes Reviews Application of Bioinformatics for the Search of Novel Anti-Viral Therapies: Rational Design of Anti-Herpes Agents
Current Bioinformatics Hydrogen Sulfide Regulates Vascular Inflammation and its Related Signaling Pathways
Current Signal Transduction Therapy Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment
CNS & Neurological Disorders - Drug Targets Triple Reuptake Inhibitors (“Broad Spectrum” Antidepressants)
CNS & Neurological Disorders - Drug Targets The Role of the Nervous System in the Regulation of Liver Cytochrome P450
Current Drug Metabolism Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases
Current Pharmaceutical Design The Immunoregulatory Activity of Mesenchymal Stem Cells: ‘State of Art’ and ‘Future Avenues’
Current Medicinal Chemistry Biochemistry and Neurobiology of Prosaposin: A Potential Therapeutic Neuro-Effector
Central Nervous System Agents in Medicinal Chemistry The Implications of Urine Drug Testing in Pain Management
Current Drug Safety Cognitive Impairment with Vascular Impairment and Degeneration
Current Neurovascular Research Serious Game-based Intervention for Children with Developmental Disabilities
Current Pediatric Reviews Intrinsically Fluorescent Base-Discriminating Nucleoside Analogs
Mini-Reviews in Organic Chemistry IAPs, their Antagonists and their Role in Neurological Disease and Cancer
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Editorial (Thematic Issue: Neurodegeneration, Oxidative Stress, Metabolic Syndrome, Drug Design and Development: Clinical Implications)
CNS & Neurological Disorders - Drug Targets